Rozelle G. Smith

FDA investigator

Appears on 3 documents from 2017 to 2018, mostly at sites in Florida. Most often cites written procedures; deviations (21 CFR 211.100).

3
Documents on file
6.0
Observations per 483
2017
First seen
2018
Most recent

What they cite most

From 18 observations
  • 21 CFR 211.100
    Written procedures; deviations
    2
  • 21 CFR 211.165(a)
    Testing and release for distribution
    2
  • 21 CFR 211.192
    Production record review
    2
  • 21 CFR 211.67
    Equipment cleaning and maintenance
    2
  • 21 CFR 111.415
    What requirements apply to filling, assembling, packaging, labeling, and related operations?
    1
  • 21 CFR 111.560(a)(2)
    What requirements apply to the review and investigation of a product complaint?
    1

Activity by year

2017: 2, 2018: 1

Where

Florida 2 · India 1

Often inspects with

Jennifer Lalama· Marc Balzarini

Is Rozelle G. Smith coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

3 documents, newest first
FirmOpen
483 CIPLA LIMITEDNov 30, 2018 · Pune, India
483 Pharmatech LLCMay 2, 2017 · Davie, Florida
483 Chemco CorpMar 6, 2017 · Miami Lakes, Florida

About this profile

What does Rozelle G. Smith inspect?

Rozelle G. Smith appears on 3 documents on file covering 3 sites, mostly in Florida.

What do they cite most often?

21 CFR 211.100 (written procedures; deviations), followed by 21 CFR 211.165(a) and 21 CFR 211.192.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Rozelle G. Smith is dated Nov 30, 2018.